Dara Milo, a software engineer turned biotech analyst, reads her firm's experimental vaccine the way she once read code - and notices the spike-protein construct may not "terminate cleanly," persisting in tissue long after it should clear. When she flags it, she's quietly walked out of the building. Elliot Cass, a career Health Department official, has spent twenty-two years watching industry insiders revolve through government; his formal objections to the emergency authorization were logged and ignored. The two connect, joined by a cell biologist, a retired FDA regulator sitting on suppressed epidemiological data, and a newsletter journalist who publishes only what the public record can prove.
Together they assemble the documented architecture of how a dangerous question was made impossible to answer - the liability shields, the two-percent compensation approvals, the funding that dries up around inconvenient findings. They can't force proof, but they can make the silence itself part of the record.